dc.contributor.advisor | Barzegar, Abolfaz | |
dc.contributor.advisor | Rahmati, Mohammad | |
dc.contributor.advisor | Mahdieh, Nejat | |
dc.contributor.author | Akbari, Bahman | |
dc.date.accessioned | 2019-01-12T06:38:52Z | |
dc.date.available | 2019-01-12T06:38:52Z | |
dc.date.issued | 2016 | en_US |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/59560 | |
dc.description.abstract | The results of this study indicated that huscFv-PE25 can recognize and pose inhibitory effect on EGFR-overexpressing cancer cells, despite its smaller size and lower immunogenicity. This may be providing a basis for development of novel clinical therapeutic agents against EGFR-overexpressing tumor cells. | en_US |
dc.language.iso | fa | en_US |
dc.publisher | Tabriz University of Medical Sciences Faculty of Advanced Medical Science | en_US |
dc.relation.isversionof | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/59559 | en_US |
dc.subject | E. coli | en_US |
dc.subject | EGFR | en_US |
dc.subject | Pseudomonas exotoxin | en_US |
dc.subject | Immunotoxin | en_US |
dc.subject | Humanized single chain antibody | en_US |
dc.title | Preparation and evaluation of toxicity of anti-epidermal growth factor receptor (EGFR) immunotoxin containing truncated Pseudomonas aeruginosa exotoxin-A and humanized single chain fragment variable | en_US |
dc.type | Thesis | en_US |
dc.contributor.supervisor | Farajnia, Safar | |
dc.identifier.docno | 160 | en_US |
dc.contributor.department | Medical Biotechnology | en_US |
dc.description.discipline | Medical Biotechnology | en_US |
dc.description.degree | Ph.D | en_US |